
Akazo P 4000mg/500mg Injection
Marketer
Akesiss Pharma Pvt Ltd
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Akazo P 4000mg/500mg Injection
Combiflox 4000mg/500mg Injection is a dual-antibiotic formulation indicated for diverse bacterial infections. Its mechanism involves microbial eradication. Administration must be by a qualified healthcare provider; self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on infection severity. Always adhere to prescribed usage. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rash, and localized injection site reactions (pain, swelling, redness). Persistent or worsening symptoms warrant immediate medical attention. Prior to treatment, inform your physician of any antibiotic allergies, liver or kidney impairments. Dosage adjustments or alternative medications may be necessary. Use during pregnancy and lactation is generally considered safe under strict medical supervision.
Primary Ingredients of Akazo P 4000mg/500mg Injection
No text was provided to rewrite.
Uses of Akazo P 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Akazo P 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Akazo P 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Akazo P 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Akazo P 4000mg/500mg Injection works:
Akazo P Injection (4000mg/500mg) unites Piperacillin, a potent antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum counters bacterial resistance mechanisms, thereby optimizing Piperacillin's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Akazo P 4000mg/500mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Akazo P, containing 4000mg/500mg, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences to fetal development; nevertheless, research involving human subjects is scarce.
Breast feedingSAFE IF PRESCRIBED
Akazo P 4000mg/500mg Injection presents minimal risk during lactation. Research in humans indicates negligible transfer to breast milk, posing no apparent danger to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Akazo P 4000mg/500mg Injection on driving ability is unknown. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCAUTION
The 4000mg/500mg Akazo P injection requires careful administration in individuals with impaired kidney function. Dosage modification of Akazo P 4000mg/500mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Akazo P 4000mg/500mg Injection in individuals with hepatic impairment appears to pose minimal risk. Preliminary evidence indicates dose modification may be unnecessary, however, medical consultation is recommended.
What if you forget to take Akazo P 4000mg/500mg Injection :
Should you inadvertently omit a scheduled dose of Akazo P 4000mg/500mg Injection, seek advice from your physician.
Facts to Know About Akazo P 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
